北美血液辐照市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型（静脉激光血液辐照、经皮激光血液辐照和体外血液辐照）、适应症（急性白血病、淋巴瘤、实体瘤、盆腔肿瘤等）和最终用户（医院、血库、诊断诊所和研究机构）
No. of Pages: 96 | Report Code: BMIRE00027187 | Category: Life Sciences
No. of Pages: 96 | Report Code: BMIRE00027187 | Category: Life Sciences
北美血液辐照市场预计将从 2022 年的 2902 万美元增长到 2028 年的 4261 万美元。预计 2022 年到 2028 年复合年增长率为 6.6% 2028.
传染性和非传染性疾病患病率的增加有利于北美血液
辐照市场增长
在北美，辐射的发生率有所上升由于外科手术、事故、创伤病例和疾病激增而导致的输血程序；以及血液感染患病率的上升。血流感染是大量人群患病和死亡的主要原因。血流感染、基础疾病和侵入性手术在老年人群中很常见。人们对这些感染的认识不断提高，以及对输血的免疫反应增强，可能会导致并发症。在北美国家，传染性和非传染性疾病的患病率很高，包括癌症、心血管疾病、慢性肾病和中风。输血可能是治疗这些疾病过程中常见的步骤。在进行输血过程之前，细胞血液成分会受到辐射。辐射通过避免活 T 淋巴细胞的增殖来预防受者中的输血相关移植物抗宿主病 (TA-GVHD)。越来越多地使用辐照血液来治疗癌症患者，增强了免疫系统并改善了整体健康状况。
市场概览< /strong>
北美血液辐照市场已细分为美国、加拿大和墨西哥。 2022年，美国占据最大市场份额。美国在北美血液辐照市场中占据重要份额。随着传染病和非传染性疾病患病率的增加，对器官移植的需求不断增加，这可能会增加对血液辐照市场的需求。在美国造成死亡的四种主要疾病是心血管疾病、糖尿病、癌症和慢性呼吸道疾病。因此，预计该国不断增加的研究和开发将在预测期内推动美国血液照射市场的增长。
北美血液放射市场收入及预测至2028年（百万美元）
< p>
北美血液放射市场细分
< p>北美血液辐照市场按类型、适应症、最终用户和国家/地区进行细分。
日立有限公司；最佳Theratronics有限公司；辐射源技术；吉拉多尼公司； Typenex Medical 和 Actemium 是该地区血液辐照市场的领先公司。
Strategic insights for North America Blood Irradiation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 29.02 Million |
| Market Size by 2028 | US$ 42.61 Million |
| Global CAGR (2022 - 2028) | 6.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Blood Irradiation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Blood Irradiation Market is valued at US$ 29.02 Million in 2022, it is projected to reach US$ 42.61 Million by 2028.
As per our report North America Blood Irradiation Market, the market size is valued at US$ 29.02 Million in 2022, projecting it to reach US$ 42.61 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The North America Blood Irradiation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Blood Irradiation Market report:
The North America Blood Irradiation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Blood Irradiation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Blood Irradiation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Blood Irradiation Market
